CN110150673A - It is a kind of to remarkably promote the nutrient composition and preparation that calcium source efficient absorption utilizes - Google Patents
It is a kind of to remarkably promote the nutrient composition and preparation that calcium source efficient absorption utilizes Download PDFInfo
- Publication number
- CN110150673A CN110150673A CN201910385236.4A CN201910385236A CN110150673A CN 110150673 A CN110150673 A CN 110150673A CN 201910385236 A CN201910385236 A CN 201910385236A CN 110150673 A CN110150673 A CN 110150673A
- Authority
- CN
- China
- Prior art keywords
- calcium
- parts
- vitamins
- electronics
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 137
- 239000011575 calcium Substances 0.000 title claims abstract description 136
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 136
- 238000002360 preparation method Methods 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 19
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 37
- 239000011782 vitamin Substances 0.000 claims abstract description 37
- 239000002131 composite material Substances 0.000 claims abstract description 30
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims abstract description 11
- 229940068475 zinc citrate Drugs 0.000 claims abstract description 11
- 239000011746 zinc citrate Substances 0.000 claims abstract description 11
- 235000006076 zinc citrate Nutrition 0.000 claims abstract description 11
- 235000016709 nutrition Nutrition 0.000 claims abstract description 3
- 230000035764 nutrition Effects 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 35
- 239000012071 phase Substances 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 14
- 239000001354 calcium citrate Substances 0.000 claims description 14
- 239000008101 lactose Substances 0.000 claims description 14
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 13
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 13
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 13
- 239000011647 vitamin D3 Substances 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 235000010323 ascorbic acid Nutrition 0.000 claims description 8
- 229960005070 ascorbic acid Drugs 0.000 claims description 8
- 239000011668 ascorbic acid Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 7
- 235000005979 Citrus limon Nutrition 0.000 claims description 6
- 244000131522 Citrus pyriformis Species 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000001334 starch sodium octenyl succinate Substances 0.000 claims description 6
- 235000013826 starch sodium octenyl succinate Nutrition 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 claims description 4
- 230000037213 diet Effects 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 150000005691 triesters Chemical class 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002261 Corn starch Polymers 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 239000008120 corn starch Substances 0.000 claims description 3
- 229940099112 cornstarch Drugs 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 150000007522 mineralic acids Chemical class 0.000 abstract description 2
- 150000007524 organic acids Chemical class 0.000 abstract description 2
- 229960005069 calcium Drugs 0.000 description 113
- 238000002156 mixing Methods 0.000 description 20
- 239000000523 sample Substances 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 15
- 238000001914 filtration Methods 0.000 description 13
- 230000001804 emulsifying effect Effects 0.000 description 12
- 238000004321 preservation Methods 0.000 description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 206010006956 Calcium deficiency Diseases 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 4
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- 241000040710 Chela Species 0.000 description 3
- 229940042228 calcium gluconate oral solution Drugs 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- -1 organic acid anions Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- 244000046095 Psophocarpus tetragonolobus Species 0.000 description 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229940099429 polyoxyl 40 stearate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a kind of nutrient compositions that promotion calcium source efficient absorption utilizes, and are made of multi-vitamins electronics chelating calcium, zinc citrate.Wherein: multi-vitamins electronics chelates the predetermined substance that calcium is certain aspects of the present invention preparation, is mixed to prepare the present composition with special ratios and zinc citrate.Compared to inorganic acid calcium, calcium of organic acid, amino acid calcium and combinations thereof and preparation, the present composition uses multi-vitamins electronics chelating calcium as calcium source for the first time, has higher bio-dissipative and availability.While mutually being cooperateed between fully considering composition specific composition material nutrition element, single replenish the calcium caused savings and GI irritation are significantly reduced, realizes the technical effect that calcium source efficient absorption utilizes, various nutrients collaboration supplements.
Description
Technical field
The nutrient composition and preparation that calcium source efficient absorption utilizes are remarkably promoted the present invention relates to a kind of, belongs to biological doctor
The big health field of medicine.
Background technique
Calcium is macroelement indispensable in human life, and it is even dead that calcium deficiency will lead to whole body Multiple organs disorders.By
In Chinese residents with cereal for main dietary structure, calcium source content and the higher food of quality for example milk, dried small shrimp, sardine,
Sesame, hyacinth bean, kelp, nut etc. seldom enter dining table, lead to the universal calcium deficiency of Chinese.Chinese Soclety of Nutrition's statistics, it is adult every
Its calcium deficiency amount is about 400mg, the daily calcium deficiency amount of Children and teenager is 600-800mg, pregnant woman wet nurse and the daily calcium deficiency of the elderly
Amount is about 600mg.
Calcium creates benefit dazzling in the market to the objective fact of human health importance and the universal calcium deficiency of Chinese
Calcium product.Make a general survey of domestic and international calcium nutrient research and development application situation: its calcium source is predominantly inorganic/organic calcium salt;It, which is studied, applies shape
Formula is mainly single calcium source supplement, calcium source and vitamin D3Compounding, calcium source and multivitamin minerals simple combination.From lack
Calcium, mechanism of replenishing the calcium and balanced nutritious angle, the prior art at least have following bottlenecks: 1. calcium uptake utilization rate is relatively low, long
Phase or excessive supplement easily cause digestive system, urinary system deposition, lead to constipation or stone in urinary system;2. the nothing in conjunction with calcium source
There is stimulation in various degree to gastrointestinal tract in machine/organic acid anions, easily cause the gastrointestinal discomforts symptoms such as pernicious, vomiting, excessive
Or there are acid ions to put aside poisoning risk for long-term consumption;3. considering while replenishing the calcium the collaboration of other nutrients, antagonism
It is less, it is eaten for a long time unbalanced between may aggravating needed by human body nutrient.
The present invention calcium nutrient research and development application there are aiming at the problem that and bottleneck, initiative use technical solution of the present invention system
Standby multi-vitamins electronics chelating calcium is combined with zinc citrate, while realizing that calcium source is quick, efficient absorption utilizes, sufficiently
Consider collaboration, antagonism between each specific composition substance of composition and nutrient, it is ensured that each nutrient is balanced while replenishing the calcium.
Summary of the invention
The first object of the present invention is to provide a kind of nutrient composition for remarkably promoting calcium source efficient absorption and utilizing,
Two are designed to provide the preparation method of the composition;Third is designed to provide the composition application.Battalion provided by the invention
Feeding promotor composition not only remarkably promotes calcium source and is absorbed and utilized, and has and absorb fastly, without deposition and GI irritation, nutrient equilibrium
The features such as.
The first object of the present invention is achieved through the following technical solutions.
Firstly, the present invention provides a kind of nutrient composition for remarkably promoting calcium source efficient absorption and utilizing, the composition
It is made of multi-vitamins electronics chelating calcium, zinc citrate.It is characterized by:
1. multi-vitamins electronics chelates calcium system by homogeneous homogenization process, using sodium carboxymethylcellulose slurrying, by lemon
The abundant homogeneous homogenate of lemon acid calcium, D-VB5 calcium, multivitamin composite powder, lactose, low temperature drying are made;Wherein, calcareous amount hundred
Dividing content is 14.14%~18.65%, preferably 15.89%~17.40%, further preferably 16.63%~16.67%.
2. by mass percentage, accounting is 0.51%~0.80%, preferably 0.61% to zinc citrate in the composition
~0.74%, further preferably 0.65%~0.70%.
Secondly, by weight, the multi-vitamins electronics chelates calcium, by parts by weight 1397.73~2329.43
Part calcium citrate, 4.37~7.64 parts of D-VB5 calcium, 2.40~5.20 parts of multivitamin composite powder, 678.12~
978.12 parts of lactose is homogenized using 1.0%~3.0% sodium carboxymethylcellulose homogeneous and is made.
Preferably, the multi-vitamins electronics chelates calcium, by 1759.52~1966.16 parts of lemon of parts by weight
Sour calcium, 5.46~7.64 parts of D-VB5 calcium, 3.32~4.72 parts of multivitamin composite powder, 753.15~903.12 parts
Lactose is homogenized using 1.5%~2.5% sodium carboxymethylcellulose homogeneous and is made.
It is further preferred that the multi-vitamins electronics chelates calcium, by 1860.00~1865.84 parts of parts by weight
Calcium citrate, 7.36~7.64 parts of D-VB5 calcium, 3.63~4.42 parts of multivitamin composite powder, 826.37~
829.26 parts of lactose is homogenized using 1.8%~2.2% sodium carboxymethylcellulose homogeneous and is made.
Again, the multivitamin composite powder communicates Over emulsfication homogeneous by water phase, oil, spray drying is made.It is special
Sign is: water phase is ascorbic acid, vitamin B1, vitamin B2, starch Sodium Octenyl Succinate, cornstarch, maltodextrin
One or more of;Oily is mutually vitamin D3, vitamin E, vitamin A, sunflower oil, one of Glycerin, mixed triester with caprylic acid capric acid or
It is several.
Further, the mass percent of the multivitamin composite powder, water phase and oily phase is 10.4~15.9:
84.1~89.6, preferably 11.2~14.0:86.0~88.8, further preferably 12.0~13.4:86.6~88.0.
Still further, the multivitamin composite powder contains vitamin D based on mass percentage3For 0.25%~
0.55%, preferably 0.25%~0.40%, further preferably 0.25%~0.30%;It is 1%~5% containing ascorbic acid,
Preferably 2%~5%, further preferably 3%~4%.
The second object of the present invention is realized by following technical proposals.
Preparation method of composition provided by the invention includes the preparation of multivitamin composite powder, multi-vitamins electronics chelating
Calcium preparation, the present composition prepare three steps:
Step 1: the preparation of multivitamin composite powder
The preparation of water phase: aqueous phase substance is mixed and sets kettle, adds appropriate amount of water in 50 DEG C or less low temperature stirring and dissolvings, sufficiently stirs
Mix to solution it is uniform, stablize be suspended, 100 mesh filter screens filtration, filtrate heat preservation it is spare.
The preparation of oily phase: oil phase substance being mixed and sets oil cauldron, and 60 DEG C or less low-temperature heats are dissolved to solution clear,
The filtration of 100 mesh filter screens, filtrate heat preservation are spare.
Emulsifying homogeneous: it is -0.08~-0.06Mpa that emulsion pot, which is evacuated to vacuum degree, and water phase is evacuated to emulsion pot, is heated
It is kept the temperature to 55 DEG C.Maintain vacuum degree constant, the oily phase of suction under stirring, heat preservation, pressure maintaining emulsifying homogeneous 30 minutes, microscopy inclusion rate >=
95% discharging.
Spray drying: emulsifying homogeneous liquid is spray-dried, and multivitamin composite powder, granularity >=100 mesh is made.
Step 2: the chelated calcium preparation of multi-vitamins electronics
1. the multi-vitamins powder of step 1 preparation is mixed with lactose, appropriate amount of water is added to dissolve, 100 mesh filtration, filtrate moves to
Homogeneous refiner.
2. calcium citrate mixed 80 meshes with D-VB5 calcium, it is added slowly in homogeneous refiner, is fully ground to paste
Shape.
3. sodium carboxymethylcellulose slurrying, standing takes supernatant to be added slowly to homogeneous refiner, adjusts homogeneous refiner
To 3000 revs/min, abundant homogeneous is homogenized 30 minutes revolving speed.
4. homogeneous homogenate crushed 80 meshes in 60 DEG C or less low temperature dryings, multi-vitamins electronics chelating calcium is obtained.
Step 3: the preparation of composition
Zinc citrate is crossed 80 meshes and is moved back to three mixing machines, and the multi-vitamins electronics chelating of step 2 preparation is added
Calcium, booting mixing 30-45 minutes, range estimation upper, middle and lower layer powder color one to upper, middle and lower layer calcium mass percentage testing result
It discharges when RSD≤2%, the present composition is made.
The purpose of third of the present invention, is achieved through the following technical solutions.
Firstly, the present composition contains calcium, zinc and multi-vitamins, multivitamin, mineral nutrient can be used as
Source is applied to drug, health food, functional ordinary food, special medicine formula food, special diet food.
Secondly, the present composition can add or not add drug, health food, functional ordinary food, special medicine
Formula food, the acceptable auxiliary material of special diet food, are made pulvis, granule, tablet, capsule, soft capsule, capsule and pill, drop
A variety of oral preparations such as ball.
The present composition can be used as calcium, zinc and multivitamin source,
Compared to inorganic acid calcium, calcium of organic acid, amino acid calcium and combinations thereof and preparation, the present composition uses for the first time
Multi-vitamins electronics chelates calcium as calcium source, has higher bio-dissipative and availability.Fully considering composition spy
While determining mutually to cooperate between component nutrient, savings and GI irritation caused by single replenish the calcium are significantly reduced, is realized
The technical effect that calcium source efficient absorption utilizes, various nutrients collaboration supplements.
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to
Limit the present invention.
The preparation 1 of example 1 group conjunction object
Step 1: the preparation 1 of multivitamin composite powder
The preparation of water phase: by vitamin B112mg, matrix starch Sodium Octenyl Succinate 61.5mg, cornstarch 183mg
Kettle is set in mixing, adds appropriate amount of water in 50 DEG C or less low temperature stirring and dissolvings, is stirred well to that solution is uniform, stablizes and is suspended, the filter of 100 mesh
Net filtration, obtains water phase 256.5mg, and filtrate heat preservation is spare.
The preparation of oily phase: by vitamin D3Oil is set in 0.9mg, vitamin A 0.6mg, matrix Glycerin, mixed triester with caprylic acid capric acid 42mg mixing
Pot, 60 DEG C or less low-temperature heats are dissolved to solution clear, and the filtration of 100 mesh filter screens obtains oily phase 43.5mg, and filtrate heat preservation is standby
With.
Emulsifying homogeneous: it is -0.08~-0.06Mpa that emulsion pot, which is evacuated to vacuum degree, and water phase is evacuated to emulsion pot, is heated
It is kept the temperature to 55 DEG C.Maintain vacuum degree constant, the oily phase of suction under stirring, heat preservation, pressure maintaining emulsifying homogeneous 30 minutes, microscopy inclusion rate >=
95% discharging.
Spray drying: emulsifying homogeneous liquid is spray-dried, obtained multivitamin composite powder 300mg, granularity >=100 mesh,
Through detecting vitamin D3Content be 0.3%.
Step 2: the chelated calcium preparation 1 of multi-vitamins electronics
1. the multivitamin composite powder 0.3g of step 1 preparation is mixed with lactose 70g, appropriate amount of water is added to dissolve, the filter of 100 mesh
It crosses, filtrate moves to homogeneous refiner.
2. calcium citrate 142g mixed 80 meshes with D-VB5 calcium 0.45g, it is added slowly in homogeneous refiner, sufficiently
It is ground to paste.
3. 1.0% sodium carboxymethylcellulose slurrying, standing takes supernatant to be added slowly to homogeneous refiner, and it is even to adjust homogeneous
To 3000 revs/min, abundant homogeneous is homogenized 30 minutes pulp grinder revolving speed.
4. homogeneous homogenate crushed 80 meshes in 60 DEG C or less low temperature dryings, multi-vitamins electronics chelating calcium is obtained
212.75g, the content for being detected calcium is 16.12%.
Step 3: the preparation 1 of composition
Zinc citrate 1.4g crosses 80 meshes and moves back to three mixing machines, adds the multi-vitamins electronics chela of step 2 preparation
Close calcium 212.75g, booting mixing 30-45 minutes, range estimation upper, middle and lower layer powder color one to upper, middle and lower layer calcium mass percentage
It discharges when testing result RSD≤2%, 1 214.15g of the present composition is made, the content for being detected calcium is 16.01%.
The preparation 2 of 2 composition of embodiment
Step 1: the preparation 2 of multivitamin composite powder
The preparation of water phase: by vitamin B25mg, matrix starch Sodium Octenyl Succinate 75mg, maltodextrin 365.5mg are mixed
Kettle is set in conjunction, adds appropriate amount of water in 50 DEG C or less low temperature stirring and dissolvings, is stirred well to that solution is uniform, stablizes and is suspended, 100 mesh filter screens
Filtration, obtains water phase 445.5mg, and filtrate heat preservation is spare.
The preparation of oily phase: by vitamin D3Oil is set in 2mg, vitamin E 2.5mg, matrix Glycerin, mixed triester with caprylic acid capric acid 50mg mixing
Pot, 60 DEG C or less low-temperature heats are dissolved to solution clear, and the filtration of 100 mesh filter screens obtains oily phase 54.5mg, and filtrate heat preservation is standby
With.
Emulsifying homogeneous: the preparation method is the same as that of Example 1.
Spray drying: emulsifying homogeneous liquid is spray-dried, obtained multivitamin composite powder 500mg, granularity >=100 mesh,
Through detecting vitamin D3Content be 0.4%.
Step 2: the chelated calcium preparation 2 of multi-vitamins electronics
1. the multivitamin composite powder 0.5g of step 1 preparation is mixed with lactose 78g, appropriate amount of water is added to dissolve, the filter of 100 mesh
It crosses, filtrate moves to homogeneous refiner.
2. calcium citrate 164.7g mixed 80 meshes with D-VB5 calcium 0.57g, it is added slowly in homogeneous refiner, fills
Divide and is ground to paste.
3. 1.8% sodium carboxymethylcellulose slurrying, standing takes supernatant to be added slowly to homogeneous refiner, and it is even to adjust homogeneous
To 3000 revs/min, abundant homogeneous is homogenized 30 minutes pulp grinder revolving speed.
4. homogeneous homogenate crushed 80 meshes in 60 DEG C or less low temperature dryings, multi-vitamins electronics chelating calcium is obtained
243.77g, the content for being detected calcium is 16.32%.
Step 3: the preparation 2 of composition
Zinc citrate 1.6g crosses 80 meshes and moves back to three mixing machines, adds the multi-vitamins electronics chela of step 2 preparation
Close calcium 243.77g, booting mixing 30-45 minutes, range estimation upper, middle and lower layer powder color one to upper, middle and lower layer calcium mass percentage
It discharges when testing result RSD≤2%, 2 245.37g of the present composition is made, the content for being detected calcium is 16.21%.
The preparation 3 of 3 composition of embodiment
Step 1: the preparation 3 of multivitamin composite powder
The preparation of water phase: by ascorbic acid 14.16mg, matrix starch Sodium Octenyl Succinate 118mg, maltodextrin
Kettle is set in 274.704mg mixing, adds appropriate amount of water in 50 DEG C or less low temperature stirring and dissolvings, it is uniform, stable mixed to be stirred well to solution
Outstanding, the filtration of 100 mesh filter screens obtains water phase 406.864mg, and filtrate heat preservation is spare.
The preparation of oily phase: by vitamin D32.36mg, vitamin E 1.416mg, matrix sunflower oil 61.36mg mixing are set
Oil cauldron, 60 DEG C or less low-temperature heats are dissolved to solution clear, and the filtration of 100 mesh filter screens obtains oily phase 65.136mg, and filtrate is protected
Warm standby is used.
Emulsifying homogeneous: the preparation method is the same as that of Example 1.
Spray drying: emulsifying homogeneous liquid is spray-dried, obtained multivitamin composite powder 472mg, granularity >=100 mesh,
Through detecting vitamin D3Content be 0.5%, ascorbic acid content 3.0%.Step 2: multi-vitamins electronics is chelated calcium
Preparation 3
1. the multivitamin composite powder 0.472g of step 1 preparation is mixed with lactose 96.3g, appropriate amount of water is added to dissolve, 100
Mesh filtration, filtrate move to homogeneous refiner.
2. calcium citrate 230g mixed 80 meshes with D-VB5 calcium 0.63g, it is added slowly in homogeneous refiner, sufficiently
It is ground to paste.
3. 2.5% sodium carboxymethylcellulose slurrying, standing takes supernatant to be added slowly to homogeneous refiner, and it is even to adjust homogeneous
To 3000 revs/min, abundant homogeneous is homogenized 30 minutes pulp grinder revolving speed.
4. homogeneous homogenate crushed 80 meshes in 60 DEG C or less low temperature dryings, multi-vitamins electronics chelating calcium is obtained
327.402g, the content for being detected calcium is 16.96%.
Step 3: the preparation 3 of composition
Zinc citrate 2.07g crosses 80 meshes and moves back to three mixing machines, adds the multi-vitamins electronics of step 2 preparation
Chelate calcium 327.402g, booting mixing 30-45 minutes, range estimation upper, middle and lower layer powder color one to the calcareous amount percentage of upper, middle and lower layer
It discharges when content detection result RSD≤2%, 3 329.472g of the present composition is made, the content through detecting calcium is
16.85%.
The preparation 4 of 4 composition of embodiment
Step 1: the preparation 4 of multivitamin composite powder
The preparation of water phase: by ascorbic acid 0.32g, matrix starch Sodium Octenyl Succinate 1.36g, maltodextrin 5.268g
Kettle is set in mixing, adds appropriate amount of water in 50 DEG C or less low temperature stirring and dissolvings, is stirred well to that solution is uniform, stablizes and is suspended, the filter of 100 mesh
Net filtration, obtains water phase 6.948g, and filtrate heat preservation is spare.
The preparation of oily phase: by vitamin D3Oil cauldron is set in 0.02g, vitamin E 0.032g, matrix sunflower oil 1g mixing,
60 DEG C or less low-temperature heats are dissolved to solution clear, and the filtration of 100 mesh filter screens obtains oily phase 1.052g, and filtrate heat preservation is spare.
Emulsifying homogeneous: the preparation method is the same as that of Example 1.
Spray drying: emulsifying homogeneous liquid is spray-dried, obtained multivitamin composite powder 8.00g, granularity >=100 mesh,
Through detecting vitamin D3Content be 0.25%, ascorbic acid content 4.0%.Step 2: multi-vitamins electronics chelates calcium
Preparation 4
1. the multivitamin composite powder 4.00g of step 1 preparation is mixed with lactose 828.12g, appropriate amount of water is added to dissolve, 100
Mesh filtration, filtrate move to homogeneous refiner.
2. calcium citrate 1863.00g mixed 80 meshes with D-VB5 calcium 7.64g, it is added slowly in homogeneous refiner,
It is fully ground to paste.
3. 2.0% sodium carboxymethylcellulose slurrying, standing takes supernatant to be added slowly to homogeneous refiner, and it is even to adjust homogeneous
To 3000 revs/min, abundant homogeneous is homogenized 30 minutes pulp grinder revolving speed.
4. homogeneous homogenate crushed 80 meshes in 60 DEG C or less low temperature dryings, multi-vitamins electronics chelating calcium is obtained
2.7kg, the content for being detected calcium is 16.67%.
Step 3: the preparation 4 of composition
Zinc citrate 18.66g crosses 80 meshes and moves back to three mixing machines, adds the multi-vitamins electronics of step 2 preparation
Chelate calcium 2.7kg, booting mixing 30-45 minutes, range estimation upper, middle and lower layer powder color one to upper, middle and lower layer calcium mass percentage
It discharges when testing result RSD≤2%, 4 2.72kg of the present composition is made, the content for being detected calcium is 16.54%.
Embodiment 5: the preparation of granule
Composition 200g prepared by Example 4 through wet granulation, squeezes sieving, the obtained granule of 50 DEG C of low temperature dryings.
Embodiment 6: the preparation of tablet
Composition 200g prepared by Example 4 adds sodium carboxymethyl starch, PVP K30, Magnesium Stearate proper quantity, warp
Mixing, granulation, tabletting, are made tablet.
Embodiment 7: the preparation of capsule
Composition 200g prepared by Example 4 adds suitable amount of sucrose, lactose, microcrystalline cellulose, silica, tristearin
Sour magnesium, through mixing, granulation, filling, hard capsule processed.
Embodiment 8: the preparation of dripping pill
Example 4 prepare composition 200g, add appropriate Macrogol 4000, Macrogol 6000, odium stearate,
Glycerol, gelatin, polyoxyl 40 stearate through mixing, dissolution, pill, polish obtained dripping pill.
In order to further be illustrated to present composition technical effect, the present invention chooses group prepared by embodiment 4
Conjunction object is test specimen, and number is 6., it is real to choose commercially available low calcium feed, calcium carbonate, calcium gluconate oral solution with effect and the present invention
Apply the calcium citrate that example 4 uses, multi-vitamins electronics chelating calcium prepared by embodiment 4 is control sample, 1. number is respectively
Commercially available low calcium feed, 2. calcium carbonate, 3. calcium citrate, 4. calcium gluconate oral solution with effect, 5. multi-vitamins electronics chelate calcium, open
Calcium apparent absorptivity and the test of calcium storage rate are opened up, as a result as follows:
Calcium apparent absorptivity and storage rate measurement
1. instrument and material
Zoonit700 atomic absorption spectrophotometer: Jena, Germany production
SD rat (Sprague-Dawley): 4 week old, weight 70-80g, cleaning grade;Feeding environment: temperature (22 ± 2)
DEG C, humidity 60% ± 5%.Shanghai western Poole-Bi Kai experimental animal Co., Ltd provides
Low calcium feed: commercially available.Calcium content is 0.1%;
Calcium carbonate (analysis is pure): commercially available.Calcium carbonate content is 99.8% (being equivalent to calcium 39.96%);
Calcium gluconate oral solution with effect: commercially available.100mg/ml containing calcium gluconate (is equivalent to calcium 9mg/ml)
Calcium citrate: (being equivalent to calcium 23.60%) containing calcium citrate 97.84%
Multi-vitamins electronics chelates calcium: calcium content 16.67%
The present composition: calcium content 16.54%
2. experimental method
(1) dosage
Composition (sample is 6.) 60kg adult's dosage is determined as 2.72g/ days, rolls over accordingly according to the present invention
Calculating daily rat dosage is 0.283g/kg BW, while 1. group gives isodose deionized water, the dosage such as foundation to sample
It is administered daily referring to composition of the present invention (adult human body mass 60kg) than principle (using the dosage of calcium as parameter)
Take in calcium content 450mg, conversion control sample daily administration dosage is sample 2. 0.12g/kg BW, sample 3. 0.20g/kg
BW, sample 4. 5.21ml/kg BW, sample 5. 0.281g/kg BW.
(2) rat experimental group and feeding patterns
SD rat after a week, selects the weight rat that there was no significant difference 60 through adaptable fed, is divided into 6 groups: low calcium
Feed control group (1.), calcium carbonate group (2.), calcium citrate group (3.), calcium gluconate group (4.), multi-vitamins electronics chela
Calcium group (5.), composition group (6.) are closed, every group of 1O is only.Each group rat ad lib low calcium feed drinks deionized water, in this base
Daily stomach-filling is carried out on plinth to raise 8 weeks.
(3) measurement of calcium apparent absorptivity and storage rate
Rat body weight need to weigh daily, feed to after 4 weeks rat being put into collection 3d excrement, urine to 100 in metabolic cage
Dry in DEG C air dry oven, grinds the results are shown in Table 1 using calcium content in Flame Atomic Absorption metabolin after constant weight.
Calcium apparent absorptivity (%)=(intake calcium-excrement calcium)/intake calcium × 100
Calcium storage rate (%)=(intake calcium-excrement calcium-urinary calcium)/intake calcium × 100
1 calcium apparent absorptivity of table and storage rate measurement (N=10)
As shown in Table 1, sample 6. compared to sample 2., 3., the 4. extremely significant reduction (P < 0.01) of excrement calcium content, compared to
5. excrement calcium content significantly reduces (P < 0.05) to sample;Sample 6. compared to sample 2., 3. extremely significant reduction (the P < of urinary calcium content
0.01), compared to sample, 4., 5. urinary calcium content significantly reduces (P < 0.05);6. compared to sample, 2., 3., 4. calcium is apparent for sample
The extremely significant raising (P < 0.01) of absorptivity, calcium storage rate content, compared to sample 5. calcium apparent absorptivity, calcium storage rate content
It is significant to increase (P < 0.05);I.e. 6. (present composition) sample shows that good promotion calcium source is absorbed and utilized and improves calcium
The activity of storage rate.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to restrict the invention, all in essence of the invention
Made any modifications, equivalent replacements, and improvements etc., should all be included in the protection scope of the present invention within mind and principle.
Claims (9)
1. a kind of nutrient composition for remarkably promoting calcium source efficient absorption and utilizing chelates calcium, lemon by multi-vitamins electronics
Sour zinc composition.It is characterized by:
1. multi-vitamins electronics chelates calcium system and uses sodium carboxymethylcellulose slurrying, by calcium citrate, D-VB5 calcium, Duo Zhongwei
Raw element composite powder, lactose are homogenized by homogeneous, and low temperature drying is made.Wherein, calcium mass percentage be 14.14%~
18.65%, preferably 15.89%~17.40%, further preferably 16.63%~16.67%.
2. by mass percentage, zinc citrate in the composition accounting be 0.51%~0.80%, preferably 0.61%~
0.74%, further preferably 0.65%~0.70%.
2. multi-vitamins electronics as described in claim 1 chelates calcium, by 1397.73~2329.43 parts of lemon of parts by weight
Lemon acid calcium, 4.37~7.64 parts of D-VB5 calcium, 2.40~5.20 parts of multivitamin composite powder, 678.12~978.12 parts
Lactose, using 1.0%~3.0% sodium carboxymethylcellulose homogeneous be homogenized be made.
3. as multi-vitamins electronics claimed in claims 1-2 chelates calcium, by 1759.52~1966.16 parts of parts by weight
Calcium citrate, 5.46~7.64 parts of D-VB5 calcium, 3.32~4.72 parts of multivitamin composite powder, 753.15~903.12
The lactose of part is homogenized using 1.5%~2.5% sodium carboxymethylcellulose homogeneous and is made.
4. the multi-vitamins electronics as described in claim 1-3 chelates calcium, by 1860.00~1865.84 parts of parts by weight
Calcium citrate, 7.36~7.64 parts of D-VB5 calcium, 3.63~4.42 parts of multivitamin composite powder, 826.37~829.26
The lactose of part is homogenized using 1.8%~2.2% sodium carboxymethylcellulose homogeneous and is made.
5. the multivitamin composite powder as described in claim 1-4 communicates Over emulsfication homogeneous by water phase, oil, spray drying is made
?.It is characterized by: water phase is ascorbic acid, vitamin B1, vitamin B2, starch Sodium Octenyl Succinate, cornstarch, wheat
One or more of bud dextrin;Oily is mutually vitamin D3, vitamin E, vitamin A, sunflower oil, in Glycerin, mixed triester with caprylic acid capric acid
It is one or more of.
6. multivitamin composite powder as claimed in claim 5, it is characterised in that: the mass percent of water phase and oily phase is
10.4~15.9:84.1~89.6, preferably 11.2~14.0:86.0~88.8, further preferably 12.0~13.4:86.6
~88.0.
7. the multivitamin composite powder as described in claim 5-6, it is characterised in that: based on mass percentage, contain vitamin D3
It is 0.25%~0.55%, preferably 0.25%~0.40%, further preferably 0.25%~0.30%;It is containing ascorbic acid
1%~5%, preferably 2%~5%, further preferably 3%~4%.
8. the nutrient composition as described in claim 1-7, it is characterised in that: the composition can be used as multivitamin, mine
Material nutrition usually source is applied to drug, health food, functional ordinary food, special medicine formula food, special diet food
Product.
9. the nutrient composition as described in claim 1-8, it is characterised in that: the composition can add or not add drug,
Health food, functional ordinary food, special medicine formula food, the acceptable auxiliary material of special diet food, be made pulvis,
The many kinds of solids oral preparation such as granula, tablet, capsule, soft capsule, capsule and pill, dripping pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910385236.4A CN110150673A (en) | 2019-05-09 | 2019-05-09 | It is a kind of to remarkably promote the nutrient composition and preparation that calcium source efficient absorption utilizes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910385236.4A CN110150673A (en) | 2019-05-09 | 2019-05-09 | It is a kind of to remarkably promote the nutrient composition and preparation that calcium source efficient absorption utilizes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110150673A true CN110150673A (en) | 2019-08-23 |
Family
ID=67633920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910385236.4A Pending CN110150673A (en) | 2019-05-09 | 2019-05-09 | It is a kind of to remarkably promote the nutrient composition and preparation that calcium source efficient absorption utilizes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110150673A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1408363A (en) * | 2002-07-31 | 2003-04-09 | 北京世纪劲得保健品有限公司 | Equalizing nutrient effervescent tablet and its preparing method |
CN102716087A (en) * | 2012-05-31 | 2012-10-10 | 浙江中同科技有限公司 | Vitamin powder and preparation method thereof |
CN104187624A (en) * | 2014-08-07 | 2014-12-10 | 逯明福 | Comprehensive nutrition powder and preparation method thereof |
US20160278415A1 (en) * | 2015-01-30 | 2016-09-29 | Nutrient Foods, Llc | Food Compositions Containing All Essential Nutrients |
US20160324204A1 (en) * | 2015-01-22 | 2016-11-10 | Mingfu LU | Complete Nutritional Powder and Preparation Method Thereof |
-
2019
- 2019-05-09 CN CN201910385236.4A patent/CN110150673A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1408363A (en) * | 2002-07-31 | 2003-04-09 | 北京世纪劲得保健品有限公司 | Equalizing nutrient effervescent tablet and its preparing method |
CN102716087A (en) * | 2012-05-31 | 2012-10-10 | 浙江中同科技有限公司 | Vitamin powder and preparation method thereof |
CN104187624A (en) * | 2014-08-07 | 2014-12-10 | 逯明福 | Comprehensive nutrition powder and preparation method thereof |
US20160324204A1 (en) * | 2015-01-22 | 2016-11-10 | Mingfu LU | Complete Nutritional Powder and Preparation Method Thereof |
US20160278415A1 (en) * | 2015-01-30 | 2016-09-29 | Nutrient Foods, Llc | Food Compositions Containing All Essential Nutrients |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101564163B (en) | Food for reducing blood sugar and blood fat and preparation method thereof | |
CN103230021B (en) | Weight-loss health-care food and preparation method thereof | |
CN102697802A (en) | Composite calcium preparation and preparation method thereof | |
CN101416747A (en) | A kind of solid low-energy food that is rich in dietary fiber and preparation method thereof | |
CN104146197A (en) | Jelly powder for invigorating stomach and improving digestion of infants and preparation method of jelly powder | |
CN105211687A (en) | A kind of composition and method of making the same and purposes | |
CN106102484A (en) | For reducing the compositions comprising Flos abelmoschi manihot of absorption of dietary fat | |
CN101828718A (en) | High-fiber fruit and vegetable nutrition package and preparation method thereof | |
CN105176772A (en) | Tartary buckwheat base liquor, tartary buckwheat liquor and production methods thereof | |
CN109674054A (en) | A kind of preparation method of the oligomeric saccharide complex of water solubility curcumin and its solid beverage | |
CN103734694B (en) | A kind of Calcium-supplementinhealth health food and preparation method thereof | |
CN111567794A (en) | Swallowing protective agent and preparation method thereof | |
CN104489681A (en) | Composition with function of enhancing immunity, health product and preparation method thereof | |
CN102150852B (en) | Toxin-eliminating and skin-beautifying convenience food and preparation method thereof | |
CN104415188A (en) | L-carnitine tea polyphenol capsule and preparation method thereof | |
CN108208741A (en) | A kind of functionality edible salt, Cardia Salt and savory flavor and preparation method thereof | |
CN107281218A (en) | A kind of high-selenium corn is combined calcium-supplementing preparation and preparation method thereof | |
CN104544047B (en) | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof | |
CN106465946A (en) | A kind of loosening bowel to relieve constipation dietary fiber | |
CN109907197A (en) | Complete nutritional composition and preparation method thereof | |
CN105433382B (en) | A kind of maca composition and its preparation method and application | |
CN107319242A (en) | L-cn effervescent tablet for slimming and preparation method thereof | |
CN110150673A (en) | It is a kind of to remarkably promote the nutrient composition and preparation that calcium source efficient absorption utilizes | |
CN106237021B (en) | A kind of composite type formulation for replenishing calcium and preparation method thereof | |
CN101589806A (en) | A kind of solid low-energy food that is rich in dietary fiber and polyethylene glycol and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190823 |